Clinical trial
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally…
NCT00328614 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00328614 |
|---|---|
| Title | Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer |
| Official title | A Phase I Pilot Study of Samarium-153 Combined With Neoadjuvant Hormonal Therapy and Radiation Therapy in Men With Locally Advanced Prostate Cancer |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Collaborators | Cytogen Corporation Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Device, Drug |
| Interventions | Samarium-153, Total Androgen Suppression (TAS) with Bicalutamide, Total androgen suppression (TAS) with Goserelin Acetate, Radiation Therapy |
| Enrollment | 32 |
| Start date | Mar 1, 2003 |
| Primary completion | Feb 1, 2009 |
| Completion | Jun 1, 2011 |
| First posted | May 22, 2006 |
| Last update posted | May 16, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: